New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

Related Keywords

New York ,United States ,Boston ,Massachusetts ,University Of Pennsylvania ,Pennsylvania ,Beth Israel Medical Center ,Philadelphia ,Rochester ,University Of Rochester ,Los Angeles ,Larry Corey ,Emily Henderson ,University Of Alabama ,Beth Israel Deaconess Medical Center ,National Institutes Of Health ,National Institute Of Allergy ,Scripps Consortium ,York Blood Center ,University Of Pittsburgh ,Professor At Scripps Research ,Vaccine Development ,Fred Hutchinson Cancer Research Center ,William Schief ,Scripps Research ,Executive Director ,Vaccine Design ,Principal Investigator ,Fred Hutchinson Cancer Research ,Columbia Physicians ,New York Blood Center ,Seattle Vaccine Trials Unit ,National Institute ,Infectious Diseases ,National Institutes ,Shiv ,Vaccine ,Kids ,Antibodies ,Dancer ,Clinical Trial ,Covid 19 ,Enetic ,Hiv Aids ,Immune System ,Protein ,Research ,Ibonucleic Acid ,Cars ,Ars Cov 2 ,Spike Protein ,Virus ,